The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly
Open accessAbstract
Purpose Early-stage non-small cell lung cancer (NSCLC) incidence among older adults is expected to increase due to demographic trends and CT-based screening, yet optimal treatment in the elderly remains controversial. Using the SEER-Medicare cohort spanning 2001–2007, we compared survival outcomes associated with five strategies used in contemporary practice: lobectomy, sublobar resection, conventional radiation, stereotactic ablative radiotherapy (SABR) and observation. Methods and Materials Treatment strategy and covariates were determined in 10,923 patients age≥66 with stage IA-IB NSCLC. Cox regression, adjusted for patient and tumor factors, compared overall and disease-specific survival for the five strategies. In a second, exploratory analysis, propensity-score matching was used for comparison of SABR with other options. Results Median age was 75 years and 29% had moderate-to-severe comorbidities. Treatment distribution was lobectomy (59%), sublobar resection (11.7%), conventional radiation (14.8%), observation (12.6%), and SABR (1.1%). In Cox regression with median follow up of 3.2 years, SABR was associated with the lowest risk of death within six months of diagnosis (HR 0.48; 95%CI 0.38–0.63; referent is lobectomy). After six months, lobectomy was associated with the best overall and disease-specific survival. In the propensity-score matched analysis, survival after SABR was similar to lobectomy (HR 0.71; 95%CI 0.45–1.12). Conventional radiation and observation were associated with poor outcomes in all analyses. Conclusions In this population-based experience, lobectomy was associated with the best long-term outcomes in fit elderly patients with early-stage NSCLC. Exploratory analysis of SABR early-adopters suggests efficacy comparable to surgery in select populations. Evaluation of these therapies in randomized trials is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Cited by
Humphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Nagata, Y., Hiraoka, M., Shibata, T., Onishi, H., Kokubo, M., Karasawa, K., Shioyama, Y., Onimaru, R., Kozuka, T., Kunieda, E., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2278 · Cited by 449
Eguchi, T., Kameda, K., Lu, S., Bott, M. J., Tan, K. S., Montecalvo, J., Chang, J. C., Rekhtman, N., Jones, D. R., Travis, W. D., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.005 · Cited by 300
Self-citationAshworth, A., Rodrigues, G., Boldt, G., & Palma, D. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.026 · Cited by 282
Chang, J. Y., Liu, Y., Zhu, Z., Welsh, J. W., Gomez, D. R., Komaki, R., Roth, J. A., & Swisher, S. G. (2013) · Cancer · doi:10.1002/cncr.28217 · Cited by 91
Metadata
- Authors
- Shirvani, S. M., Jiang, J., Chang, J. Y., Welsh, J. W., Gomez, D. R., Swisher, S., Buchholz, T. A., & Smith, B. D.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 84
- Issue
- 5
- Pages
- 1060-1070
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2056221208
- Cited by
- 250
- References
- 2
- FWCI
- 22.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.